Status:
UNKNOWN
A Study of rTMS Personalized Precision Treatment of Post-stroke Depression
Lead Sponsor:
Zhujiang Hospital
Conditions:
Post-stroke Depression
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
This is a multicenter, randomized trial aims to reveal the efficacy and safety of Repetitive transcranial magnetic stimulation (rTMS) individualized therapy based on the 'emotional loop destabilizatio...
Detailed Description
This is a multicenter, randomized trial aims to reveal the efficacy and safety of rTMS individualized therapy based on the 'emotional loop destabilization' mechanism of PSD .One hundred and twenty par...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- （1） First-time ischemic stroke with clinical and MRI or CT findings of basal ganglia stroke (ICD-10-CM code 293.83\[F06.32\]) (3) Right-handedness (4)Clear consciousness (5)Aged 25-75 years with a recent (less than 24 months) ischemic stroke;
- Exclusion Criteria
- Aphasia or severe cognitive impairment, severe hearing impairment;
- Contraindications of MRI scan and rTMS treatment such as pacemaker implantation; (3)Depression caused by psychoactive substances and non addictive substances;（4）Prior history of depressive disorders or major trauma within 1 year, severe depression or any other severe mental disorders;
- （5）Pregnant or breast-feeding women; （6）Refusal to sign informed consent of this study
Exclusion
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03256305
Start Date
December 1 2016
End Date
October 1 2021
Last Update
March 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhujiang hospital
Guangzhou, Guangdong, China, 510000